Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:
Net income (loss)	$ 28,462	$ (19,386)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	410	972
(Gain) loss on extinguishment of debt	(53)	27,479
Gain from change in fair value of hybrid financial instruments	(21,809)	(11,926)
Gain from change in fair value of derivative liability - warrants	(3,067)	(11,347)
(Gain) loss from change in fair value of derivative liability - Series C and D preferred stock and debentures	(1,841)	13,035
Deferred taxes	(706)	0
Stock-based compensation expense	1	14
Bad debt expense	0	457
Interest expense added to liabilities	0	4,406
Gain on derecognition of accrued expenses and purchase price guarantee	0	(8,300)
Impairment loss on cash surrender value of life insurance policy	0	527
Changes in operating assets and liabilities:
Accounts receivable	(68)	0
Prepaid expenses and other assets	84	63
Accounts payable and accrued liabilities	(331)	555
Deferred revenue and other current liabilities	(1,481)	1,915
Net cash used in operating activities	(399)	(1,536)
Cash Flows from Investing Activities:
Acquisition of property and equipment	0	(3)
Proceeds received from life insurance policy	0	126
Net cash provided by investing activities	0	123
Cash Flows from Financing Activities:
Payments on convertible debt instruments	0	(450)
Borrowings under convertible debentures	0	2,500
Borrowings under short-term notes payable	110	0
Payments on short-term notes payable	(54)	0
Net cash provided by financing activities	56	2,050
Effect of exchange rate changes on cash	(1)	(56)
Net change in cash and cash equivalents	(344)	581
Cash and cash equivalents, beginning of year	611	30
Cash and cash equivalents, end of year	267	611
Supplemental cash flow information:
Interest paid during the period	5	31
Series C preferred stock converted to common stock	10	878
Series D preferred stock converted to common stock	0	2,342
Convertible debentures converted to common stock	4,233	17,138
Deemed dividend on Series C preferred stock conversion	16	0
Deemed dividend on convertible debentures conversion	$ 726	$ 0